Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0660
+0.0020 (3.13%)
Feb 19, 2026, 4:10 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 67.3 million as of February 18, 2026. Its market cap has increased by 70.54% in one year.
Market Cap
67.30M
Enterprise Value
60.37M
Revenue
4.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 67.30M, an increase of 1,075.59%. That is a compound annual growth rate of 9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 67.30M | -23.81% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 104.85M |
| LTR Pharma | 89.98M |
| Cynata Therapeutics | 87.03M |
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 80.44M |
| Imugene | 78.77M |
| Radiopharm Theranostics | 77.97M |
| Neurizon Therapeutics | 66.11M |